| pubmed-article:17026489 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C0025598 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C0289313 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C0205318 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:17026489 | lifeskim:mentions | umls-concept:C0556895 | lld:lifeskim |
| pubmed-article:17026489 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17026489 | pubmed:dateCreated | 2006-10-9 | lld:pubmed |
| pubmed-article:17026489 | pubmed:abstractText | This study assessed the efficacy and safety of rosiglitazone and metformin (RSG/MET) fixed-dose combination (AVANDAMET) as initial therapy in patients with uncontrolled type 2 diabetes compared with monotherapy with either RSG or MET after 32 weeks of treatment. | lld:pubmed |
| pubmed-article:17026489 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17026489 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17026489 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17026489 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:17026489 | pubmed:issn | 1462-8902 | lld:pubmed |
| pubmed-article:17026489 | pubmed:author | pubmed-author:ChowNN | lld:pubmed |
| pubmed-article:17026489 | pubmed:author | pubmed-author:RosenstockJJ | lld:pubmed |
| pubmed-article:17026489 | pubmed:author | pubmed-author:GarberAA | lld:pubmed |
| pubmed-article:17026489 | pubmed:author | pubmed-author:RookAA | lld:pubmed |
| pubmed-article:17026489 | pubmed:author | pubmed-author:BiswasNN | lld:pubmed |
| pubmed-article:17026489 | pubmed:author | pubmed-author:CobitzAA | lld:pubmed |
| pubmed-article:17026489 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17026489 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:17026489 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17026489 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17026489 | pubmed:pagination | 650-60 | lld:pubmed |
| pubmed-article:17026489 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:meshHeading | pubmed-meshheading:17026489... | lld:pubmed |
| pubmed-article:17026489 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17026489 | pubmed:articleTitle | Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes. | lld:pubmed |
| pubmed-article:17026489 | pubmed:affiliation | Dallas Diabetes and Endocrine Center, Dallas, TX 75230, USA. juliorosenstock@dallasdiabetes.com | lld:pubmed |
| pubmed-article:17026489 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17026489 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17026489 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17026489 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17026489 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17026489 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17026489 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17026489 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17026489 | lld:pubmed |
